HBK Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,250,000
Closed -$137M 466
2023
Q2
$137M Buy
+3,250,000
New +$131M 0.74% 11
2020
Q4
Sell
-150,000
Closed -$7.97M 780
2020
Q3
$7.97M Buy
+150,000
New +$8.93M 0.06% 143
2017
Q4
Sell
-90,030
Closed -$4.71M 1176
2017
Q3
$4.71M Buy
90,030
+39,530
+78% +$2.2M 0.03% 269
2017
Q2
$2.95M Buy
50,500
+30,100
+148% +$1.56M 0.02% 330
2017
Q1
$935K Sell
20,400
-8,754
-30% -$436K 0.01% 425
2016
Q4
$1.53M Sell
29,154
-31,446
-52% -$1.52M 0.01% 394
2016
Q3
$2.7M Buy
60,600
+18,600
+44% +$807K 0.02% 310
2016
Q2
$1.6M Buy
+42,000
New +$1.85M 0.01% 468
2016
Q1
Sell
-26,100
Closed -$1.27M 1157
2015
Q4
$1.27M Sell
26,100
-6,510
-20% -$290K 0.01% 512
2015
Q3
$1.3M Buy
+32,610
New +$1.42M 0.01% 522

Other funds holding SYNH

HBK Investments's SYNH Position: Q3 2023 in Review

HBK Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 3,250,000 shares — an estimated $137M sold.

HBK Investments first reported a position in SYNH in Q3 2015 and held it in 10 quarters. The position peaked at $137M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • HBK Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 3,250,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $137M.
  • HBK Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 10 quarters.
  • HBK Investments's Syneos Health, Inc. Class A Common Stock position peaked at $137M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.